Gurlek, F.; Tasdemir, E. Is It an Advantage or Disadvantage to Usage Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in COVID-19 Patients?. Int J Res Med Sci 2020, 8, 4200-4205.